clear search
Search
Search Suggestions
Recent searches Clear History
Contact Us

Recognizing overlapping autoimmune diseases in thyroid disease for primary care clinicians

Guideline
EliA™ autoimmune test solutions

Published: December 2025

Medically reviewed by:
Mercè Tena Campos, Scientific Affairs Manager


Female provider checking a woman's wrist and arm muscles

Polyautoimmunity refers to the presence of two or more autoimmune diseases in the same patient.1 Because symptoms overlap, many patients experience prolonged diagnostic journeys before the correct diagnosis is made. Early recognition and first-line testing in primary care can reduce time to diagnosis and prevent complications.2,3

Why Graves’ and Hashimoto’s often coexist with other autoimmune diseases

  • Autoimmune thyroid diseases (AITDs) commonly co-occur with other autoimmune conditions. Cohort and systematic review data show that between one in three and one in six autoimmune thyroid patients also had another autoimmune disease, most often celiac disease, autoimmune gastritis/pernicious anemia, rheumatoid arthritis, vitiligo, type 1 diabetes, or Sjögren’s syndrome.4,5
Expand to show autoimmune diseases frequently associated with autoimmune thyroid diseases.5
  Additional autoimmune condition All AITD patients Hashimoto’s thyroiditis patients Graves’ disease patients
More common Type 1 diabetes mellitus 3.6 % 4.4 % 2.9 %
Autoimmune gastritis 3.4 % 3.5 % 3.3 %
Rheumatoid arthritis 2.6 % 2.4 % 2.6 %
Celiac disease 2.3 % 2.7 % 1.2 %
Vitiligo 2.4 % 2.7 % 2.1 %
Pernicious anemia 1.8 % 3.9 % 1.4 %
Less common Sjögren’s syndrome 1.2 % 1.2 % 0.8 %
 
  • Many patients with autoimmune thyroid diseases continue to feel unwell even when their thyroid treatment is correct. One of the reasons could be the presence of other autoimmune conditions, known as polyautoimmunity.6
  • Risk factors for multiple autoimmune diseases include family history, female gender and genetic predisposition.7,8

Red flags for thyroid patients

Recognized signs and symptoms

  • Unexplained iron-deficiency anemia or macrocytosis9,10
  • Persistent gastrointestinal problems: bloating, diarrhea, malabsorption9,11
  • Symmetrical small-joint pain or stiffness; sicca symptoms; Raynaud’s phenomenon12,13
  • Depigmented skin or hair14-16
  • Recurrent polyuria, hypoglycemia, or unexplained weight change17

Less obvious but important

  • Chronic fatigue, anxiety, or low mood despite normal thyroid levels6,18
  • Cognitive “brain fog”6
  • Glossitis or burning tongue; persistent dyspepsia19,20
  • Subtle rashes or very dry skin9,13
  • Recurrent miscarriage or infertility problems9,11

Common autoimmune conditions to consider in thyroid patients

Celiac disease

Classic symptoms: Diarrhea, steatorrhea, failure to thrive, features of malnutrition or malabsorption, abdominal pain, weight loss, bloating, indigestion, flatulence, nausea/vomiting, constipation.9

Non-classic and other shared symptoms: Unexplained iron deficiency anemia, peripheral neuropathy (tingling, numbness, pain in hands and feet), neurological symptoms (headaches, cognitive issues), osteoporosis, infertility, dermatitis herpetiformis, vitamin deficiencies (folic acid and B12), chronic migraine, chronic fatigue, difficulty losing weight, dental enamel defects.11,21

What can be done in primary care: Screen thyroid patients who have gastrointestinal red flags, other relevant symptoms or family history.9,11 Ensure the patient is eating gluten before testing; refer to gastroenterology if serology is positive.9

Recommended tests: 

  • tTG-IgA plus total IgA.9
  • Pediatric no-biopsy pathway if tTG ≥10x ULN plus EMA positive.22
  • In adults, very high tTG-IgA ± EMA may support no-biopsy diagnosis in selected centers per local protocol.23,24

Why it matters: Many celiac patients present with extra-intestinal features (anemia, osteoporosis, infertility) rather than diarrhea. Missed diagnoses prolong suffering and risk complications.25,26 Testing from primary care is simple and cost-effective.9,27

Systemic autoimmune rheumatic diseases (including rheumatoid arthritis, Sjögren’s syndrome and other connective tissue diseases)

Classic symptoms (disease dependent): Joint pain, skin rashes, organ dysfunction, fatigue, dry eyes or mouth.12,13,28

Non-classic and other shared symptoms: Raynaud’s phenomenon,  pleurisy, arthralgia, myopathy, malaise, weight loss, alopecia, sclerodactyly, telangiectasia.13,28

What can be done in primary care: Early detection and urgent referral are crucial.29,30

Recommended tests:

  • Order rheumatoid factor (RF) and antibodies against cyclic citrullinated peptides (anti-CCP, ACPA or CCP); double positivity indicates priority referral.29
  • ANA as first-line for systemic rheumatic autoimmune diseases;31 interpret using guidance from laboratory.

Why it matters: Combined RF IgM isotype and anti-CCP positivity is highly predictive of rheumatoid arthritis, while a single RF isotype may not be associated with a significant risk to develop rheumatoid arthritis.29,32-33 Sjögren’s syndrome frequently clusters with thyroid autoimmunity; sicca symptoms plus thyroid disease should raise suspicion.5 Early rheumatology referral improves outcomes and prevents joint damage.29

Autoimmune gastritis and pernicious anemia

Classic symptoms: Often asymptomatic at first.10,28 Later: iron or vitamin B12 deficiency, anemia/pallor, glossitis, diarrhea, peripheral numbness, loss of vibratory sense.28

Non-classic and other shared symptoms: Fatigue, weakness, dyspepsia, neurological problems.10

What can be done in primary care: Consider in older patients with macrocytosis; test for antibodies against parietal cells and intrinsic factor, serum gastrin and antibodies against Helicobacter pylori.20,28,34 Positive or suspicious results → refer for endoscopy.20
Why it matters: Autoimmune gastritis and pernicious anemia are part of the “thyrogastric disease” spectrum.35 Gastric cancer risk must be remembered.34 Screening for thyroid autoimmunity is recommended in autoimmune gastritis.34 Early detection avoids irreversible neurologic complications from B12 deficiency.10

Type 1 diabetes mellitus

Classic symptoms: Polyuria, polydipsia, blurred vision, weight change.36

Non-classic and other shared symptoms: Impaired wound healing, increased infections, fatigue.28,36

What can be done in primary care: Glucose is the first and most relevant test; if unstable, start fluids/electrolytes/insulin and refer immediately.28,36

Why it matters: Patients with autoimmune thyroid diseases are at higher risk for type 1 diabetes and latent autoimmune diabetes should be considered in adults.17 Untreated hyperglycemia or delayed recognition can lead to diabetic ketoacidosis, which is life-threatening.36

Vitiligo

Classic symptoms: Skin, hair, and oral depigmentation.14,15

Non-classic/other shared symptoms and impact: Psychosocial impact.16

What can be done in primary care: Classic cases can be diagnosed in primary care; atypical cases → dermatology. In adults with vitiligo, consider thyroid function tests.14

Why it matters: Vitiligo is the most common cause of acquired depigmentation.15 It is often the earliest visible autoimmune sign and can precede thyroid disease.15 Several chemicals (hair dyes, cleaning products, cosmetics) have been reported as triggers.16

The value of early recognition and testing

Early testing in primary care can shorten the diagnostic journey, improve care and avoid unnecessary referrals. Patients with persistent symptoms could feel unheard if their complaints are dismissed as “just thyroid.” By considering polyautoimmunity and testing for other autoimmune diseases, you can validate patient concerns and improve outcomes.2,3 Early action also reduces costs and prevents complications.37

You don’t have to be an autoimmune specialist to make a difference. Your role as a GP is to:

  • Recognize red flags, including relevant symptoms and family history
  • Test appropriately (celiac disease: tTG-IgA + total IgA; systemic rheumatic diseases: rheumatoid factor + anti-CCP ± antinuclear antibody screening)
  • Refer to gastroenterology, rheumatology or other specialists if test results are positive or if clinical suspicion remains high

Thermo Fisher Scientific provides reliable autoimmune testing solutions and resources that can help you simplify decision-making, improve patient journeys and deliver coordinated care.

References
  1. Anaya JM. The diagnosis and clinical significance of polyautoimmunity. Autoimmun Rev. 2014;13(4-5):423-426.
  2. Urruticoechea-Arana A, et al. Development of an application for mobile phones (App) based on the collaboration between the Spanish Society of Rheumatology and Spanish Society of Family Medicine for the referral of systemic autoimmune diseases from primary care to rheumatology. Reumatol Clin (Engl Ed). 2020;16(5):373-377.
  3. Gunning JN. ‘But you don’t look sick’: Memorable messages of emerging adulthood autoimmune disease. J Soc Pers Relat. 2023;40(6):2008-2030.
  4. Franco JS et al. Thyroid disease and autoimmune diseases. In: Anaya JM, Shoenfeld Y, Rojas-Villarraga A, et al., editors. Autoimmunity: From Bench to Bedside [Internet]. Bogota (Colombia): El Rosario University Press; 2013. Chapter 30.
  5. Botello A, et al. Prevalence of latent and overt polyautoimmunity in autoimmune thyroid disease: A systematic review and meta-analysis. Clin Endocrinol (Oxf). 2020;93(4):375-389.
  6. Groenewegen KL, et al. Persisting symptoms in patients with Hashimoto’s disease despite normal thyroid hormone levels: Does thyroid autoimmunity play a role? A systematic review. J Transl Autoimmun. 2021;4:100081
  7. Rojas-Villarraga A et al. Introducing polyautoimmunity: secondary autoimmune diseases no longer exist. Autoimmune Dis. 2012;2012:254319.
  8. Conrad N, et al. Incidence, prevalence, and co-occurrence of autoimmune disorders over time. Lancet. 2023.
  9. Al-Toma A, et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J. 2019;7(5):583-613.
  10. Castellana C et al. Autoimmune Atrophic Gastritis: A Clinical Review. Cancers. 2024;16(7):1310.
  11. Zingone F, et al. Celiac disease-related conditions: Who to test? Gastroenterology. 2024;167(1):64-78.
  12. Tagoe CE. Rheumatic symptoms in autoimmune thyroiditis. Curr Rheumatol Rep. 2015;17(2):5.
  13. NHS Lanarkshire. Connective tissue disease referral guideline. Right Decisions NHS Scotland. 2024. Available from: https://rightdecisions.scot.nhs.uk/nhsl-referral-pathways/rheumatology-referral-pathways/connective-tissue-disease-referral-guideline/.
  14. Gawkrodger DJ et al. Guideline for the diagnosis and management of vitiligo. Br J Dermatol. 2008;159:1051-1067
  15. Baldini E, et al. Vitiligo and autoimmune thyroid disorders. Front Endocrinol. 2017;8:290.
  16. Ezzedine K et al. Recent clinical and mechanistic insights into vitiligo offer new treatment options for cell-specific autoimmunity. J Clin Invest. 2025;135(2):e185785
  17. Page CP, et al. Latent autoimmune diabetes of adulthood: case report. Clin Diabetes Endocrinol. 2017;3:11
  18. Siegmann EM, et al. Association of depression and anxiety disorders with autoimmune thyroiditis: A systematic review and meta-analysis. JAMA Psychiatry. 2018;75(6):577-584.
  19. Boukssim S, et al. Navigating pernicious anemia: oral health as a window to systemic disease. Curr Oral Health Rep. 2025;12(5):1-10.
  20. Taylor L, et al. Creating a framework for treating autoimmune gastritis—the case for replacing lost acid. Nutrients. 2024;16(5):662.
  21. Gujral N et al. Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol. 2012;18(42):6036-6059.
  22. Husby S et al. European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020. J Pediatr Gastroenterol Nutr. 2020;70(1):141-156.
  23. Shiha MG, et al. Exploring the views of primary and secondary care physicians on the no-biopsy diagnosis of coeliac disease in adults: a qualitative interview study. Frontline Gastroenterol. 2025;16(2):101-107.
  24. Al-Toma A, et al. European Society for the Study of Coeliac Disease 2025 updated guidelines on the diagnosis and management of coeliac disease in adults. Part 1: diagnostic approach. United Eur Gastroenterol J. 2025;13(10):1-32.
  25. Lindfors K, et al. Coeliac disease. Nat Rev Dis Primers. 2019;5(3):1-21.
  26. Cappello M, et al. Elderly-onset celiac disease: a narrative review. Clin Med Insights Gastroenterol. 2016;9:41-49.
  27. Heijdra Suasnabar, J.,et al. (2024). Long-Term Cost-Effectiveness of Case Finding and Mass Screening for Celiac Disease in Children. Gastroenterology, 167(6), 1129–1140.
  28. Shoenfeld Y, et al. The general practice guide to autoimmune diseases. Pabst Sci Publ. 2012;1(1):1-316.
  29. Blasco Á, et al. Double positivity for rheumatoid factor and anti-CCP autoantibodies: improving referral from primary care of patients suspected of having rheumatoid arthritis. Prim Health Care Res Dev. 2024;25(6):e6:1-6.
  30. Inchingolo F, et al. Management of rheumatoid arthritis in primary care: a scoping review. Int J Environ Res Public Health. 2024;21(6):662.
  31. Agmon-Levin N, et al. International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis. 2014;73(1):17-23.
  32. Jónsson T, et al. Elevation of only one rheumatoid factor isotype is not associated with increased prevalence of rheumatoid arthritis—a population-based study. Scand J Rheumatol. 2000;29(3):190-191.
  33. Jaskowski TD, et al. Relationship between rheumatoid factor isotypes and IgG anti-cyclic citrullinated peptide antibodies. J Rheumatol. 2010;37(8):1515-1523.
  34. Shah SC, et al. AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review. Gastroenterology. 2021;161(4):1325-1332.e7.
  35. Katayama T, et al. Significance of an early diagnosis of autoimmune gastritis in nonelderly patients with type 1 diabetes mellitus and autoimmune thyroid disease: a case report. Intern Med. 2025;64(3):2587-2591.
  36. NHS. Symptoms of type 1 diabetes and how it's diagnosed. NHS.uk. 2024. Available from: https://www.nhs.uk/conditions/type-1-diabetes/symptoms/.
  37. van Mulligen E, et al. Early identification of rheumatoid arthritis: does it induce treatment-related cost savings? Ann Rheum Dis. 2024;83(12):1647-1656.